Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.
Symptom overlap in anxiety and multiple sclerosis.
Fatal Neuroinflammation in a Case of Multiple Sclerosis with Anti-Natalizumab Antibodies.
miRNA in multiple sclerosis: search for novel biomarkers.
Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study.
Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab.
Partnering to increase access to community exercise programs for people with stroke, acquired brain injury, and multiple sclerosis.
Laquinimod Halted MS Disability But Not Relapses
Cognitive impairment as unusual first manifestation in late-onset relapsing-remitting multiple sclerosis.
Epistasis and immunity: the role of genetic interactions in autoimmune diseases.
Prospective Examination of Anxiety and Depression Before and During Confirmed and Pseudoexacerbations in Patients With Multiple Sclerosis.
[Multiple sclerosis: new approaches to comprehensive treatment and rehabilitation using the method of reflexology].
Naltrexone
The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities.
Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.
Association of IL4 and IL4R polymorphisms with multiple sclerosis susceptibility in Caucasian population: A meta-analysis.
Multiple sclerosis disease-modifying therapy prescribing patterns in ontario.
No Regional Gray Matter Atrophy Differences between Pediatric- and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration.
The effect of vitamin a supplementation on disease progression, cytokine levels and gene expression in multiple sclerotic patients: study protocol for a randomized controlled trial.
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis.
Association between apolipoprotein E gene polymorphism and the risk of multiple sclerosis: A meta-analysis of 6977 subjects.
Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis.
Proton Density MRI Increases Detection of Cervical Spinal Cord Multiple Sclerosis Lesions Compared with T2-Weighted Fast Spin-Echo.

Pages